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The data is related to the research article entitled “Arf6 mediates
Schwann cell differentiation and myelination” [1]. To further
investigate the role of Arf6 in promoting myelination by Schwann
cells in vivo, we have characterized an another line (2) of small-
hairpin (sh)RNA transgenic mice targeting Arf6. The number of
transgenes per one allele in this line was very low (2 transgenes),
comparing with high copies in the previous line (1, 20 transgenes)
[1]. In 4 days of neonatal age, transgenic mice exhibited decreased
myelin thickness; however, decreased levels were not as much as
those in the line 1, likely depending on transgene copy number. In
60-day-old mice, the difference became smaller. On the other
hand, transgene's effect was not related to cell proliferation and
apoptosis. These data support the key role of Arf6 in Schwann cell
myelination, especially in the initiation.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Value of the data
 The data from g-ratios, the numerical ratios of the axon diameter to the diameter of the outermost
myelinated ﬁbers, provide the difference between transgenic mice and the littermate controls.
 The average g-ratios from neonatal mice support that Arf6 preferentially regulates the initiation of
myelination.
 The effect is not responsible for cell growth and apoptosis.1. Data, experimental design, materials and methods
1.1. Generation of Arf6 shRNA transgenic mouse
Mouse Arf6 shRNA oligonucleotides, corresponding to the siRNA target sequences (50-AAGAA-
TATCAGCTTCACCGTG-30 and 50-AAGATCCGGCCGCTCTGGCGG-30), were inserted into the BLOCK-iT
PolII-miR-RNAi expression vector (Life Technologies), followed by ampliﬁcation with the 704-2010
bases. The MPZ promoter (GenBank Acc. No. M62857) for Schwann cells and the ampliﬁed region
containing shRNA-inserted artiﬁcial miRNA and polyA signal were successively inserted into sub-
cloning vector. A DNA fragment (2.7-kb) containing all nucleotide units was digested from the
vector backbone with EcoRI and PstI, puriﬁed, and injected into fertilized C57BL/6J oocytes, resulting
in acquiring 2 founders. The original names (lines C and B) have been now designated as line 1 and
line 2, respectively. Transgenic founder mice and established transgenic mice were routinely iden-
tiﬁed by tail DNA's genomic PCR with primers 1 and 2 (50-ATGGTGAGCAAGGGCGAGGAGCTG-30 and
50-CTTGTACAGCTCGTCCATGCCGAGAGTGATC-30, respectively). They were also identiﬁed by Southern
blotting with BamHI-digested tail DNA hybridized to a radioisotope-labeled genomic probe speciﬁc
for the transgene [1]. The transgenic allele resulted in a hybridized band of 1.0 kb and the hybri-
dized band was compared with the copy number standard. The line 1 harbored 20 copies per allele
[1] whereas the line 2 did 2 copies in this study.
1.2. Immunoblotting
Mouse sciatic nerves were lysed in lysis buffer (50 mM HEPES-NaOH, pH 7.5, 20 mM MgCl2,
150 mM NaCl, 1 mM dithiothreitol, 1 mM phenylmethane sulfonylﬂuoride, 1 μg/ml leupeptin, 1 mM
EDTA, 1 mM Na3VO4, and 10 mM NaF) containing detergents (0.5% NP-40, 1%CHAPS, and 0.1%SDS).
These detergents are important for myelin protein isolation [1]. Equal amounts of the proteins (20 mg
Fig. 1. Expression of Arf6 in Arf6 shRNA transgenic mice. Transgenic mouse and littermate control mouse sciatic nerves at
7 days old (3 independent mice) were lysed and immunoblotted with an antibody against MPZ, Arf1 or 6, or actin. The
representative immunoblots are shown.
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of the TransBlot TurboTransfer System (Bio-Rad, Hercules, CA, USA). The transferred membranes were
blocked with a Blocking One kit (Nacalai) and immunoblotted using primary antibodies (anti-Arf1
and anti-Arf6 [Santa Cruz Biotechnology], and MPZ and actin [MBL]), followed by peroxidase-
conjugated secondary antibodies (Nacalai). The bound antibodies were detected using an Immu-
noStar Zeta kit (Wako). In Arf6 shRNA transgenic mice, decreased expression levels of Arf6 and myelin
marker MPZ were observed. In contrast, those of Arf1 and control actin were comparable in trans-
genic mice and littermate controls (Fig. 1).
1.3. Electron microscopy of mouse sciatic nerve
Mouse sciatic nerves were ﬁxed with 2% paraformaldehyde and 2% glutaraldehyde in 0.1% caco-
dylate buffer. The tissues were postﬁxed with buffered 2% osmium tetroxide, dehydrated with an
ethanol gradient, treated with acetone, and embedded in epoxy resin. Ultrathin sections of cross
sections were stained with uranyl acetate and lead citrate. They were observed and photographed
with Hitachi or JEOL electron microscope system [1,2]. Myelinated nerves in cross sections were
randomly taken and the g-ratio, the numerical ratio of the axon diameter to the diameter of the
outermost myelinated ﬁber of each axon, and the average were calculated. Thinner myelin sheaths
yield larger g-ratios. 4-day-old transgenic mice exhibited decreased myelin thickness compared to
littermate controls (0.7470.063 in transgenic mice vs. 0.7170.062 in controls, p¼0.0068; Fig. 2).
Decreased levels were not as much as those in the line 1 [1], likely depending on transgene copy
number. While similar results were observed in 60-day-old transgenic mice (0.6470.069 in trans-
genic mice vs. 0.6070.049 in controls, p¼0.0056; Fig. 3), the difference became smaller.
1.4. Mouse sciatic nerve staining
Tissues were perfused ﬁrst with PBS and then with PBS containing 4% paraformaldehyde. They
were postﬁxed with 4% paraformaldehyde, which was subsequently replaced with 20% sucrose, and
Fig. 2. 4-Day-old Arf6 shRNA transgenic mice exhibit decreased myelin thickness. (A) The representative electron micrographs
of control (Ctrl) or transgenic (Tg) mouse sciatic nerve cross sections are shown. The scale bars indicate 2 mm. (B) The g-ratios
are plotted for axon diameters. The average g-ratio and the p-value are also shown in the graph. The n number indicates total
number of appreciably counted myelinated axons from 3 independent mice. (C) The data are presented in the form of the
relative distributions of the g-ratios.
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bated ﬁrst with primary antibody (Cell Signaling Technology) against cell proliferation marker Ki67 or
active caspase 3 and then with ﬂuorescence-labeled secondary antibodies. The glass coverslips were
mounted with DAPI-containing Vectashield. The ﬂuorescent images were captured using DM2500
microscope system and analyzed using a LAS software (Leica) or captured using BX51 microscope
system and analyzed using a DP2-BSW software (Olympus) [1,2]. Ki67- or active caspase 3-staining
Fig. 3. 60-Day-old Arf6 shRNA transgenic mice also exhibit decreased myelin thickness. (A) The representative electron
micrographs of control or transgenic mouse sciatic nerve cross sections are shown. The scale bars indicate 2 mm. (B) The g-
ratios are plotted for axon diameters. The average g-ratio and the p-value are also shown in the graph. The n number indicates
total number of appreciably counted myelinated axons from 3 independent mice. (C) The data are presented in the form of the
relative distributions of the g-ratios.
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Fig. 4. Ki67-staining. (A) In 7-day-old sciatic nerve cross sections of Arf6 shRNA transgenic and control mice, cells positive for
the cell proliferation antigen Ki67 are shown in green ﬂuorescence. The representative nuclear DAPI staining is also shown in
blue ﬂuorescence. Since sciatic nerve cross sections mainly contain Schwann cell bodies and nerve ﬁbers, DAPI-staining nuclei
are nearly identical with Schwann cell nuclei. The scale bars indicate 100 mm. The arrows indicate examples of Ki67-positive
cells. (B) The number of Ki67-positive cells per section (n¼4 independent mice) is shown in the graph.
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Fig. 5. Active caspase 3-staining. (A) In 7-day-old sciatic nerve cross sections of Arf6 shRNA transgenic and control mice, cells
positive for the apoptotic active caspase 3 are shown in red ﬂuorescence. The representative nuclear DAPI staining is also
shown in blue ﬂuorescence. The scale bars indicate 100 mm. The arrows indicate examples of active caspase 3-positive cells.
(B) The number of active caspase 3-positive cells per section (n¼4 independent mice) is shown in the graph.
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signiﬁcant in Ki67- or active caspase 3-staining sections.
1.5. Statistical analysis
Data are presented as mean 7 SD from independent experiments. Intergroup comparisons were
performed using unpaired Student's t test. Differences were considered signiﬁcant when p value is
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